Skip to main content

2023 SSO Annual Meeting Main banner

Tweets by 2023 SSO Annual Meeting

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Speaker

Browse by Speaker

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Y
Yaffe, Michael

National Cancer Institute
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Michael Yaffe
Yakoub, Danny

Medical College of Georgia-Augusta University
Upper GI Poster Presentations 1
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Danny Yakoub
Yamauchi, Takayoshi

University of Southern California - Department of Surgery
94: Single-cell profiling of tumor-infiltrating T-cell clones in longitudinal peripheral blood samples for clinical studies
Location:Ballroom A
Takayoshi Yamauchi
Yang, Anthony

Indiana University School of Medicine
P71: Are Pathologic Factors Associated with Higher Risk for Venous Thromboembolism After Gastrointestinal Cancer Surgery? A Potential Opportunity to Tailor Prophylaxis
Location:SSO HUB: Rare/Metastatic Cancers Zone
Anthony Yang
Yang, Chi-Fu

Massachusetts General Hospital
P66: Medicaid Expansion Increases Early Lung Cancer Diagnosis in Urban Blacks
Location:SSO HUB: Rare/Metastatic Cancers Zone
Chi-Fu Yang
Yang, Han-Kwang

Seoul National University Hospital
92: Long-term outcomes of proximal gastrectomy for upper third advanced gastric and Siewert type II esophagogastric junction cancers in comparison with total gastrectomy: a propensity-score matched analysis
Location:Ballroom A
Han-Kwang Yang
Yang, Wei

MD Anderson Cancer Center
7: Multicenter clinical trial for omission of breast surgery in invasive cancer following neoadjuvant systemic therapy: Longitudinal patient reported outcomes and decisional comfort planned analyses
Location:Veterans Memorial Auditorium
Wei Yang
Yazaki, Paul

Department of Immunology and Theranostics, Beckman Research Institute of the City of Hope
P83: Primary and Metastatic Gastric Cancers in Patient-derived Orthotopic Xenografts Brightly Labeled by Fluorescent anti-CEA Antibody
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Paul Yazaki
Yee, Elliott

University of Colorado
P38: Dynamic anthropometrics: sarcopenia and survival in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Elliott Yee
Yip, Linwah

University of Pittsburgh Medical Center
Evaluation of Adrenal Masses in Patients with Secondary Malignancy
Location:Ballroom C
Linwah Yip
Questions and Discussion
Location:Ballroom C
Linwah Yip
Yonkus, Jennifer

Mayo Clinic
70: Oncologic outcomes of cytoreductive surgery and HIPEC for highly selected patients with pancreatic ductal adenocarcinoma
Location:Ballroom B
Jennifer Yonkus
Yoo, James

Brigham and Women's Hospital
Surveillance and Treatment of Anal Dysplasia
Location:SSO HUB Theater
James Yoo
Yoon, Charles

Dana-Farber Brigham Cancer Center, Boston, MA, USA
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Charles Yoon
Yoon, Isabel

Perelman School of Medicine, University of Pennsylvania
P67: Neighborhood Deprivation and Breast Cancer Outcomes in Philadelphia
Location:SSO HUB: Rare/Metastatic Cancers Zone
Isabel Yoon
Yoon, Lynn

University of Texas Southwestern Medical Center
96: Serum IL-6 level predicts survival and treatment response in gastric and gastroesophageal junction cancer
Location:Ballroom A
Lynn Yoon
Yopp, Adam

UT Southwestern Medical Center
72: Cost Analysis and Financial Implications of Cytoreductive Surgery and HIPEC: a US Single Center Experience
Location:Ballroom B
Adam Yopp
Con
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Adam Yopp
Yost, Kathryn

Stanford University
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Kathryn Yost
Yuan, Hong

University of North Carolina
29: Development of a novel PET agent for parathyroid imaging targeting the Calcium-Sensing Receptor (CaSR)
Location:Ballroom A
Hong Yuan
Yu, Hongmei

Quantum Leap Healthcare Collaborative
3: Changes in axillary surgical management over 10 years – report on > 1400 breast cancer patients treated with neoadjuvant chemotherapy on I-SPY2
Location:Veterans Memorial Auditorium
Hongmei Yu
Yu, Jingjing

University of California, Irvine Medical Center
P49: Convolutional Neural Network to Predict Peritoneal Carcinomatosis Risk in Gastric Cancer
Location:SSO HUB: Rare/Metastatic Cancers Zone
Jingjing Yu
P50: Novel Vascularized Microtumor (VMT) Model of Peritoneal Carcinomatosis (PC) with Mesothelial-Lined Chambers and Submesothelial Stroma that Mimic the Peritoneal Cavity
Location:SSO HUB: Rare/Metastatic Cancers Zone
Jingjing Yu
P65: A National Assessment of Differences in Gastric Cancer Outcomes Among Asian Ethnic Subgroups
Location:SSO HUB: Rare/Metastatic Cancers Zone
Jingjing Yu
Yushak, Melinda

Emory University
55: Neoadjuvant Pepinemab in Combination with Nivolumab and/or Ipilimumab in Resectable Stage III Melanoma
Location:Veterans Memorial Auditorium
Melinda Yushak
Yuval, Jonathan

Department of Surgery, Memorial Sloan Kettering Cancer Center
21: Organ Preservation, Compliance and Toxicity in Rectal Cancer Patients Treated with Total Neoadjuvant Therapy: A Post Hoc Analysis of the of the OPRA Phase II Trial
Location:Ballroom C
Jonathan Yuval